EIKON THERAPEUTICS Trademark

Trademark Overview


On Tuesday, May 4, 2021, a trademark application was filed for EIKON THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EIKON THERAPEUTICS trademark a serial number of 90690461. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, July 26, 2024. This trademark is owned by EIKON THERAPEUTICS, INC.. The EIKON THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders, and vaccines; pharmaceutical products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; biopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; therapeutic pr...

Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells
eikon therapeutics

General Information


Serial Number90690461
Word MarkEIKON THERAPEUTICS
Filing DateTuesday, May 4, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, July 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements


Description of MarkThe mark consists of an incomplete open circle which is partially bisected by four lines forming an open triangle and incomplete open triangle, where each of the four lines are connected by filled circles; the word "eikon" is immediately adjacent and over the word "therapeutics".
Goods and ServicesPharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders, and vaccines; pharmaceutical products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; biopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; therapeutic products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; diagnostic products, preparations and agents for medicinal purposes
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesProviding a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 29, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEIKON THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Party NameEIKON THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events


Event DateEvent Description
Friday, May 7, 2021NEW APPLICATION ENTERED
Monday, September 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 5, 2022ASSIGNED TO EXAMINER
Thursday, January 6, 2022NON-FINAL ACTION WRITTEN
Thursday, January 6, 2022NON-FINAL ACTION E-MAILED
Thursday, January 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 29, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, April 29, 2022EXAMINERS AMENDMENT E-MAILED
Friday, April 29, 2022EXAMINER'S AMENDMENT ENTERED
Friday, April 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 2, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, May 2, 2022ASSIGNED TO LIE
Monday, May 2, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, May 2, 2022EXAMINERS AMENDMENT E-MAILED
Monday, May 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 2, 2022EXAMINER'S AMENDMENT ENTERED
Monday, May 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 6, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, May 6, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, May 6, 2022WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Friday, May 6, 2022EXAMINERS AMENDMENT E-MAILED
Friday, May 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 6, 2022EXAMINER'S AMENDMENT ENTERED
Friday, May 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 13, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 2, 2023SOU EXTENSION 1 FILED
Thursday, February 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 2, 2023SOU EXTENSION 1 GRANTED
Saturday, February 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 21, 2023SOU EXTENSION 2 FILED
Friday, July 21, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 21, 2023SOU EXTENSION 2 GRANTED
Tuesday, July 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 19, 2024SOU EXTENSION 3 FILED
Friday, January 19, 2024SOU EXTENSION 3 GRANTED
Tuesday, January 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 26, 2024SOU EXTENSION 4 FILED
Friday, July 26, 2024SOU EXTENSION 4 GRANTED